Paper19258089
Does reperfusion injury still cause significant mortality after lung transplantation?
Ailawadi G and 9 others. J Thorac Cardiovasc Surg, 2009. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Does reperfusion injury still cause significant mortality after lung transplantation? Papers, record 19258089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19258089
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Transplantation | Major topic |
| Reperfusion Injury | Major topic |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Severity of Illness Index | |
| Survival Rate |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| T32 HL007849 | NHLBI NIH HHS | United States | T32HL007849 | PubMed and NIH |
Source NIH RePORTER
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36354584 | Functional Blockage of S100A8/A9 Ameliorates Ischemia-Reperfusion Injury in the Lung. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/36354584 | PubMed |
| 34712133 | Diminazen Aceturate Protects Pulmonary Ischemia-Reperfusion Injury via Inhibition of ADAM17-Mediated Angiotensin-Converting Enzyme 2 Shedding. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34712133 | PubMed |
| 33050736 | Xenogeneic and Allogeneic Mesenchymal Stem Cells Effectively Protect the Lung Against Ischemia-reperfusion Injury Through Downregulating the Inflammatory, Oxidative Stress, and Autophagic Signaling Pathways in Rat. | Cell Transplant | 2020 | https://conductscience.org/library/papers/33050736 | PubMed |
| 32547733 | Improvement of lung ischemia-reperfusion injury by inhibition of microRNA-155 via reductions in neuroinflammation and oxidative stress of vagal afferent nerve. | Pulm Circ | 2020 | https://conductscience.org/library/papers/32547733 | PubMed |
| 32073901 | Nitrite attenuates mitochondrial impairment and vascular permeability induced by ischemia-reperfusion injury in the lung. | Am J Physiol Lung Cell Mol Physiol | 2020 | https://conductscience.org/library/papers/32073901 | PubMed |
| 31604167 | Silencing of lncRNA MALAT1 Prevents Inflammatory Injury after Lung Transplant Ischemia-Reperfusion by Downregulation of IL-8 via p300. | Mol Ther Nucleic Acids | 2019 | https://conductscience.org/library/papers/31604167 | PubMed |
| 31318922 | Gas6/Axl signaling attenuates alveolar inflammation in ischemia-reperfusion-induced acute lung injury by up-regulating SOCS3-mediated pathway. | PLoS One | 2019 | https://conductscience.org/library/papers/31318922 | PubMed |
| 31267824 | EXPRESS: Products of oxidative stress and TRPA1 expression in the brainstem of rats after lung ischemia-reperfusion injury. | Pulm Circ | 2019 | https://conductscience.org/library/papers/31267824 | PubMed |
| 30420790 | Shock Wave Therapy Enhances Mitochondrial Delivery into Target Cells and Protects against Acute Respiratory Distress Syndrome. | Mediators Inflamm | 2018 | https://conductscience.org/library/papers/30420790 | PubMed |
| 29609890 | Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion. | J Thorac Cardiovasc Surg | 2018 | https://conductscience.org/library/papers/29609890 | PubMed |
| 29137274 | Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets. | Oncotarget | 2017 | https://conductscience.org/library/papers/29137274 | PubMed |
| 27639818 | Revisiting successful transplantation with marginal lungs: Fourteen years later, a new era of extended criteria. | J Thorac Cardiovasc Surg | 2016 | https://conductscience.org/library/papers/27639818 | PubMed |
| 27109193 | Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor Antagonism. | Ann Thorac Surg | 2016 | https://conductscience.org/library/papers/27109193 | PubMed |
| 23865790 | Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury. | Am J Transplant | 2013 | https://conductscience.org/library/papers/23865790 | PubMed |
| 23481566 | Influence of hemodialysis on clinical outcomes after lung transplantation. | J Surg Res | 2013 | https://conductscience.org/library/papers/23481566 | PubMed |
| 21980055 | Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling. | Am J Respir Cell Mol Biol | 2012 | https://conductscience.org/library/papers/21980055 | PubMed |
| 21762933 | Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. | J Thorac Cardiovasc Surg | 2011 | https://conductscience.org/library/papers/21762933 | PubMed |
| 21317314 | Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. | Am J Respir Crit Care Med | 2011 | https://conductscience.org/library/papers/21317314 | PubMed |
| 20659747 | Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury. | J Thorac Cardiovasc Surg | 2010 | https://conductscience.org/library/papers/20659747 | PubMed |
| 20398911 | Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury. | J Thorac Cardiovasc Surg | 2010 | https://conductscience.org/library/papers/20398911 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19258089
GET https://conductscience.org/api/papers/v1/19258089/authors